Digital Monitoring in Cancer Survivors

Launched by LAURA LONGSHAW · Oct 31, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Digital Monitoring in Cancer Survivors," is exploring how digital tools can help cancer survivors manage their quality of life and symptoms after treatment. The study aims to see how well patients can use a smartwatch to track their physical activity, sleep, and heart rate, while also completing a questionnaire about their symptoms every week. By doing this, researchers hope to find out if this approach can help improve the care experience for cancer survivors without putting extra strain on healthcare services.

To participate, individuals must be at least 18 years old, have had treatment for any type of solid cancer, and be in a stable condition with no signs of active disease. They should also be under a regular follow-up plan with their healthcare team. Participants will receive a smartwatch and will be involved for about four months, during which they'll wear the watch continuously and attend a couple of research appointments. At the end of the study, they will have the chance to share their experiences in a focus group. This trial is not yet recruiting participants but will last for a total of 18 months.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Diagnosis of any solid malignancy, at any stage
• • Completion of treatment (including surgery, radiotherapy, and any kind of cytotoxic systemic anticancer treatment \[hormonal and targeted treatments allowed\])
• • Clinical, biochemical and radiological confirmation of controlled disease (no evidence of residual disease or not-progressive disease)
• • Scheduled for either a therapeutic break (from cytotoxic systemic anticancer treatment), or having completed the planned multimodal treatment
• • Scheduled for active surveillance plan within oncology service or discharged to surgical or GP care following completion of adjuvant treatment
• • Male or female patients aged at least 18 years old
• • WHO Performance Status 0-2
• Exclusion Criteria:
• • • Not in possession of a SIM card
• • No internet access through Wi-Fi or unwilling to use mobile data allowance on a daily basis
• • Unable to understand and follow the instructions autonomously
• • Uncontrolled severe comorbidities (I.e., cardiovascular, neurological, respiratory)
• • Lack of capacity
• • Unable to understand English
• • Still undergoing systemic anticancer treatment (apart from bone-targeted agents, hormonal treatment against breast or prostate cancers or maintenance monoclonal antibody monotherapy)
• • Poor general condition (PS\>2)